Development of a Novel, Oral Orexin Receptor 2 Agonist, ORX750 for Treatment of Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia

Plazzi G, Dauvilliers Y, Plante D, Mignot E, Roth T, Sterkel A, Leary EB, Hartman D, Accardi MA, Saha S, Kanes S. Development of a Novel, Oral Orexin Receptor 2 Agonist, ORX750 for Treatment of Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia. Sleep Medicine Suppl 1, Abstracts from the 18th World Sleep Congress, Sept 2025.